Ajax Health — Full Portfolio
4 tracked investments · listed companies and verified rows first
Menlo Park, US
Rush Pope(Executive Officer)Mike Carter(Executive Officer)
BoardShane Kreidel(Executive Officer)Duke Rohlen(Executive Officer, Director)Aftab Kherani(Director)
Board seatDoug Koo· per SEC Form D · $1M raise · filed Feb 2021
HealthtechBaltimore, US
Terri Burke(Executive Officer, Director)James Gammie(Director)
BoardAftab Kherani(Director)
Board seatDuke Rohlen· per SEC Form D · $8.1M raise · filed Jun 2020
BiotechPhiladelphia, US
Tony Natale(Director)Sasha Schrode(Executive Officer, Director, Promoter)Doug Koo(Mr. Koo is the Chief Financial Officer of the Issuer.)Michael Dishowitz(Mr. Dishowitz is the Secretary and Treasurer of the Issuer.)
BoardAftab Kherani(Director)
Board seatDuke Rohlen· per SEC Form D · $8M raise · filed Oct 2019
XII Medical develops neuromodulation therapies for treating obstructive sleep apnea, focusing on simplifying treatment options and improving patient outcomes.
Deep TechDigital HealthHealthtechMedical DevicesUnion City, US
Garrett Schwab(Chief Executive Officer)Shane Kreidel(Secretary and Chief Financial Officer)Zachary Eisen(Director)
BoardJD Friedland(Director)Saoussen Ben Halima(Director)
Board seatDuke Rohlen· per SEC Form D · $15.1M raise · filed Apr 2022
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.